Comparison of Vaginal PGE2 (Dinoprostone) and Vaginal Misoprostol for Induction of Labour in Primigravid Term Pregnancy
2026年4月27日 更新者:Adeel Ahmed、Mayo Hospital Lahore
This randomized controlled trial was conducted to compare vaginal misoprostol and vaginal PGE2 (dinoprostone) for induction of labour in primigravid women with term pregnancy.
Labour induction is commonly required when pregnancy reaches term but spontaneous labour has not started.
Different medicines are used to soften the cervix and start uterine contractions, but their effectiveness may vary.
A total of 240 primigravid women with singleton pregnancy at 40 weeks or more of gestation, who were not in spontaneous labour and were planned for induction of labour, were included.
Participants were allocated into two equal groups.
Women in Group M received a 50 μg vaginal misoprostol insert, while women in Group D received a 3 mg vaginal dinoprostone insert.
Both medicines were given under aseptic conditions in the inpatient obstetrics setting.
The main purpose of the study was to compare the proportion of women who achieved successful vaginal delivery after induction.
The study also assessed the time interval from first treatment to vaginal delivery among successful cases.
Additional maternal and neonatal outcomes included peripartum hemorrhage, premature rupture of membranes, and admission of the newborn to the neonatal intensive care unit within 48 hours after delivery.
研究概览
研究类型
介入性
注册 (实际的)
240
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Punjab Province
-
Lahore、Punjab Province、巴基斯坦、54000
- Mayo Hospital, Lahore
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
接受健康志愿者
不
描述
Inclusion Criteria:
- Women age 18-45 years, primigravida, undergoing induction of labour at Gestational age ≥ 40 weeks by last menstrual period (LMP)
- Not having spontaneous labor at 40 weeks of gestation by last menstrual period (LMP)
Exclusion Criteria:
- Absent fetal cardiac activity on CTG
- Non-reassuring CTG on admission
- Anomalous fetus on ante-natal ultrasound record.
- Not willing to participate.
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Group M Misoprostol
Participants in this group received 50 μg vaginal misoprostol insert under aseptic conditions for induction of labour.
|
50 μg misoprostol was administered as a vaginal insert for induction of labour in primigravid women with term pregnancy.
|
|
有源比较器:Group D Dinoprostone
Participants in this group received 3 mg vaginal dinoprostone insert under aseptic conditions for induction of labour
|
3 mg dinoprostone was administered as a vaginal insert for induction of labour in primigravid women with term pregnancy.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Successful Vaginal Delivery
大体时间:From first administration of the assigned vaginal insert until vaginal delivery, assessed up to 48 hours after first treatment administration.
|
Successful vaginal delivery was assessed as the proportion of participants who achieved vaginal delivery after induction of labour with the assigned study drug.
|
From first administration of the assigned vaginal insert until vaginal delivery, assessed up to 48 hours after first treatment administration.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Time Interval From First Treatment to Vaginal Delivery
大体时间:From first administration of the assigned vaginal insert until vaginal delivery, assessed up to 48 hours after first treatment administration.
|
The time interval from administration of the assigned vaginal insert to vaginal delivery was measured in hours among participants who achieved successful vaginal delivery.
|
From first administration of the assigned vaginal insert until vaginal delivery, assessed up to 48 hours after first treatment administration.
|
|
Peripartum Hemorrhage
大体时间:From delivery until 3 days after delivery.
|
Peripartum hemorrhage was recorded as Yes when excessive blood loss was associated with both blood transfusion during or within 3 days after delivery and a fall in hemoglobin of ≥2 g/dL from baseline.
Baseline hemoglobin was measured at admission to the labour room and post-delivery hemoglobin was assessed 48 hours after delivery.
|
From delivery until 3 days after delivery.
|
|
Neonatal Intensive Care Unit Admission
大体时间:Within 48 hours after delivery.
|
Neonatal intensive care unit admission was assessed as the proportion of newborns admitted to the neonatal intensive care unit after delivery.
|
Within 48 hours after delivery.
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Saher Anam、Mayo Hospital Lahore
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2025年10月29日
初级完成 (估计的)
2026年4月29日
研究完成 (估计的)
2026年4月29日
研究注册日期
首次提交
2026年4月21日
首先提交符合 QC 标准的
2026年4月27日
首次发布 (实际的)
2026年4月30日
研究记录更新
最后更新发布 (实际的)
2026年4月30日
上次提交的符合 QC 标准的更新
2026年4月27日
最后验证
2026年4月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.